{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:06:05Z","timestamp":1790816765921,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373350"],"award-info":[{"award-number":["82373350"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04693-8","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:14:51Z","timestamp":1783487691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lymph node metastasis-related circHELQ promotes progression and acts as a nanotherapeutic target in colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Jingwen","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengzhen","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Er","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zejian","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiatong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"4693_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer. J Clin. 2024;74:229\u201363.","journal-title":"J Clin"},{"key":"4693_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.cell.2006.11.001","volume":"127","author":"GP Gupta","year":"2006","unstructured":"Gupta GP, Massagu\u00e9 J. Cancer Metastasis: Building a Framework. Cell. 2006;127:679\u201395.","journal-title":"Cell"},{"key":"4693_CR3","doi-asserted-by":"publisher","first-page":"e150923221164","DOI":"10.2174\/1874467217666230915125622","volume":"17","author":"Y Ruan","year":"2023","unstructured":"Ruan Y, Lu G, Yu Y, et al. PF-04449913 Inhibits Proliferation and Metastasis of Colorectal Cancer Cells by down-regulating MMP9 Expression through the ERK\/p65 Pathway. Curr Mol Pharmacol. 2023;17:e150923221164.","journal-title":"Curr Mol Pharmacol"},{"key":"4693_CR4","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2174\/0109298665305114240718072029","volume":"31","author":"S Tian","year":"2024","unstructured":"Tian S, Chen M, Jing W, et al. miR-1204 Positioning in 8q24.21 Involved in the Tumorigenesis of Colorectal Cancer by Targeting MASPIN. Protein Pept Lett. 2024;31:544\u201358.","journal-title":"Protein Pept Lett"},{"key":"4693_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1001\/jama.2021.0106","volume":"325","author":"LH Biller","year":"2021","unstructured":"Biller LH, Schrag D. Diagnosis and Treatment of Metastatic Colorectal Cancer. JAMA. 2021;325:669.","journal-title":"JAMA"},{"key":"4693_CR6","first-page":"462","volume":"7","author":"MS Pepper","year":"2001","unstructured":"Pepper MS. Lymphangiogenesis and tumor metastasis: myth or reality? Clin Cancer Res. 2001;7:462\u20138.","journal-title":"Clin Cancer Res"},{"key":"4693_CR7","first-page":"295","volume":"54","author":"CC Compton","year":"2004","unstructured":"Compton CC, Greene FL. The Staging of Colorectal Cancer: 2004 and Beyond. CA: A Cancer. J Clin. 2004;54:295\u2013308.","journal-title":"J Clin"},{"key":"4693_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3393\/ac.2024.00521.0074","volume":"40","author":"G-S Choi","year":"2024","unstructured":"Choi G-S, Kim HJ. The role of lateral pelvic lymph node dissection in advanced rectal cancer: a review of current evidence and outcomes. Annals Coloproctology. 2024;40:363\u201374.","journal-title":"Annals Coloproctology"},{"key":"4693_CR9","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1111\/codi.15586","volume":"23","author":"T Sasaki","year":"2021","unstructured":"Sasaki T, Shigeta K, Okabayashi K, et al. Horizontal spread of pericolic lymph node metastasis as a prognostic factor for recurrence in Stage III colorectal cancer. Colorectal Dis. 2021;23:1370\u20138.","journal-title":"Colorectal Dis"},{"key":"4693_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/jnci\/93.8.583","volume":"93","author":"H Nelson","year":"2001","unstructured":"Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for Colon and Rectal Cancer Surgery. JNCI J Natl Cancer Inst. 2001;93:583\u201396.","journal-title":"JNCI J Natl Cancer Inst"},{"key":"4693_CR11","doi-asserted-by":"crossref","unstructured":"Jiao S, Guan X, Wei R et al. Prognostic impact of increased lymph node yield in colorectal cancer patients with synchronous liver metastasis: a population-based retrospective study of the US database and a Chinese registry. Int J of Surg. 2023;109:1932\u201340.","DOI":"10.1097\/JS9.0000000000000244"},{"key":"4693_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41568-024-00721-7","volume":"24","author":"VM Conn","year":"2024","unstructured":"Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer. 2024;24:597\u2013613.","journal-title":"Nat Rev Cancer"},{"key":"4693_CR13","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/s41592-022-01487-2","volume":"19","author":"AF Nielsen","year":"2022","unstructured":"Nielsen AF, Bindereif A, Bozzoni I, et al. Best practice standards for circular RNA research. Nat Methods. 2022;19:1208\u201320.","journal-title":"Nat Methods"},{"key":"4693_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.2174\/0109298665297110240611115010","volume":"31","author":"H Ge","year":"2024","unstructured":"Ge H, Yan Y, Wang H, et al. Circular RNA hsa_circ_0005939 Regulates UHRF1BP1L Expression by targeting miR-4693-3p to Promote Colorectal Cancer Progression. Protein Pept Lett. 2024;31:437\u201346.","journal-title":"Protein Pept Lett"},{"key":"4693_CR15","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","volume":"185","author":"C-X Liu","year":"2022","unstructured":"Liu C-X, Chen L-L. Circular RNAs: Characterization, cellular roles, and applications. Cell. 2022;185:2016\u201334.","journal-title":"Cell"},{"key":"4693_CR16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"W-Y Zhou","year":"2020","unstructured":"Zhou W-Y, Cai Z-R, Liu J, et al. Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer. 2020;19:172.","journal-title":"Mol Cancer"},{"key":"4693_CR17","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12943-024-02131-7","volume":"23","author":"Q Yi","year":"2024","unstructured":"Yi Q, Feng J, Lan W, et al. CircRNA and lncRNA-encoded peptide in diseases, an update review. Mol Cancer. 2024;23:214.","journal-title":"Mol Cancer"},{"key":"4693_CR18","doi-asserted-by":"publisher","first-page":"216825","DOI":"10.1016\/j.canlet.2024.216825","volume":"589","author":"J Lin","year":"2024","unstructured":"Lin J, Zhong W, Lyu Z, et al. Circular RNA circTATDN3 promotes the Warburg effect and proliferation in colorectal cancer. Cancer Lett. 2024;589:216825.","journal-title":"Cancer Lett"},{"key":"4693_CR19","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.drup.2024.101097","volume":"76","author":"J Lin","year":"2024","unstructured":"Lin J, Lyu Z, Feng H, et al. CircPDIA3\/miR-449a\/XBP1 feedback loop curbs pyroptosis by inhibiting palmitoylation of the GSDME-C domain to induce chemoresistance of colorectal cancer. Drug Resist Updates. 2024;76:101097.","journal-title":"Drug Resist Updates"},{"key":"4693_CR20","doi-asserted-by":"publisher","first-page":"e2204513","DOI":"10.1002\/advs.202204513","volume":"9","author":"Z Pan","year":"2022","unstructured":"Pan Z, Zheng J, Zhang J, et al. A Novel Protein Encoded by Exosomal CircATG4B Induces Oxaliplatin Resistance in Colorectal Cancer by Promoting Autophagy. Adv Sci. 2022;9:e2204513.","journal-title":"Adv Sci"},{"key":"4693_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12943-020-01179-5","volume":"19","author":"Z Pan","year":"2020","unstructured":"Pan Z, Cai J, Lin J, et al. A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer. Mol Cancer. 2020;19:71.","journal-title":"Mol Cancer"},{"key":"4693_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","volume":"55","author":"Y Eygeris","year":"2021","unstructured":"Eygeris Y, Gupta M, Kim J, et al. Chemistry of Lipid Nanoparticles for RNA Delivery. Acc Chem Res. 2021;55:2\u201312.","journal-title":"Acc Chem Res"},{"key":"4693_CR23","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.bioactmat.2020.12.010","volume":"6","author":"M Yang","year":"2021","unstructured":"Yang M, Li J, Gu P, et al. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Bioactive Mater. 2021;6:1973\u201387.","journal-title":"Bioactive Mater"},{"key":"4693_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2022","unstructured":"Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Reviews Clin Oncol. 2022;20:33\u201348.","journal-title":"Nat Reviews Clin Oncol"},{"key":"4693_CR25","doi-asserted-by":"publisher","first-page":"103514","DOI":"10.1016\/j.drudis.2023.103514","volume":"28","author":"X Huang","year":"2023","unstructured":"Huang X, Guo H, Wang L, et al. Biomimetic cell membrane-coated nanocarriers for targeted siRNA delivery in cancer therapy. Drug Discovery Today. 2023;28:103514.","journal-title":"Drug Discovery Today"},{"key":"4693_CR26","doi-asserted-by":"publisher","first-page":"6174","DOI":"10.1038\/s41467-025-61230-1","volume":"16","author":"L Cui","year":"2025","unstructured":"Cui L, Cui Y, Liu J, et al. Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion. Nat Commun. 2025;16:6174.","journal-title":"Nat Commun"},{"key":"4693_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.bioactmat.2022.10.026","volume":"23","author":"W Song","year":"2023","unstructured":"Song W, Jia P, Ren Y, et al. Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics. Bioactive Mater. 2023;23:80\u2013100.","journal-title":"Bioactive Mater"},{"key":"4693_CR28","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.2147\/IJN.S497510","volume":"20","author":"Y Li","year":"2025","unstructured":"Li Y, Sun H, Cao D, et al. Overcoming Biological Barriers in Cancer Therapy: Cell Membrane-Based Nanocarrier Strategies for Precision Delivery. Int J Nanomed Volume. 2025;20:3113\u201345.","journal-title":"Int J Nanomed Volume"},{"key":"4693_CR29","doi-asserted-by":"crossref","unstructured":"Zhang C, Pan T, Zhang Y et al. Cancer-associated fibroblasts enhance colorectal cancer lymphatic metastasis via CLEC11A\/LGR5-mediated WNT pathway activation. 2025;135:e194243.","DOI":"10.1172\/JCI194243"},{"key":"4693_CR30","doi-asserted-by":"publisher","first-page":"8389","DOI":"10.1038\/s41467-023-44133-x","volume":"14","author":"N Montenegro-Navarro","year":"2023","unstructured":"Montenegro-Navarro N, Garc\u00eda-B\u00e1ez C, Garc\u00eda-Caballero M. Molecular and metabolic orchestration of the lymphatic vasculature in physiology and pathology. Nat Commun. 2023;14:8389.","journal-title":"Nat Commun"},{"key":"4693_CR31","doi-asserted-by":"publisher","first-page":"e08352","DOI":"10.1002\/advs.202508352","volume":"12","author":"Z Huang","year":"2025","unstructured":"Huang Z, Li Y, Qian Y, et al. An LCN2-Dependent Positive\u2010Feedback Loop Between Gastric Cancer Cells and Tumor\u2010Associated\u2010Macrophages Mediates Lymphangiogenesis and Lymphatic Metastasis. Adv Sci. 2025;12:e08352.","journal-title":"Adv Sci"},{"key":"4693_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3892\/etm.2020.9552","volume":"21","author":"S Lin","year":"2020","unstructured":"Lin S, Lin M, Ma H, et al. Identification of miR-4793-3p as a potential biomarker for bacterial infection in patients with hepatitis B virus-related liver cirrhosis: A pilot study. Experimental Therapeutic Med. 2020;21:120.","journal-title":"Experimental Therapeutic Med"},{"key":"4693_CR33","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41419-021-04061-4","volume":"12","author":"M Yan","year":"2021","unstructured":"Yan M, Niu L, Liu J, et al. circEVI5 acts as a miR-4793-3p sponge to suppress the proliferation of gastric cancer. Cell Death Dis. 2021;12:774.","journal-title":"Cell Death Dis"},{"key":"4693_CR34","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s12957-025-04036-1","volume":"23","author":"Y Chang","year":"2025","unstructured":"Chang Y, Sun Z, Xu M. miR-4793-3p predicts poor prognosis and regulates ferroptosis and invasiveness of breast cancer via targeting RNF169. World J Surg Oncol. 2025;23:381.","journal-title":"World J Surg Oncol"},{"key":"4693_CR35","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1172\/JCI83967","volume":"126","author":"HM Bui","year":"2016","unstructured":"Bui HM, Enis D, Robciuc MR, et al. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD. J Clin Invest. 2016;126:2167\u201380.","journal-title":"J Clin Invest"},{"key":"4693_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.copbio.2017.01.002","volume":"46","author":"DA Scheinberg","year":"2017","unstructured":"Scheinberg DA, Grimm J, Heller DA, et al. Advances in the clinical translation of nanotechnology. Curr Opin Biotechnol. 2017;46:66\u201373.","journal-title":"Curr Opin Biotechnol"},{"key":"4693_CR37","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1080\/10717544.2021.1938757","volume":"28","author":"A Li","year":"2021","unstructured":"Li A, Zhao Y, Li Y, et al. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles. Drug Delivery. 2021;28:1237\u201355.","journal-title":"Drug Delivery"},{"key":"4693_CR38","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jconrel.2020.09.012","volume":"327","author":"P Dash","year":"2020","unstructured":"Dash P, Piras AM, Dash M. Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy. J Controlled Release. 2020;327:546\u201370.","journal-title":"J Controlled Release"},{"key":"4693_CR39","doi-asserted-by":"publisher","first-page":"e2400514","DOI":"10.1002\/adhm.202400514","volume":"13","author":"Y Ma","year":"2024","unstructured":"Ma Y, Yi J, Ruan J, et al. Engineered Cell Membrane-Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation. Adv Healthc Mater. 2024;13:e2400514.","journal-title":"Adv Healthc Mater"},{"key":"4693_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41565-023-01580-3","volume":"19","author":"M Liu","year":"2024","unstructured":"Liu M, Hu S, Yan N, et al. Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity. Nat Nanotechnol. 2024;19:565\u201375.","journal-title":"Nat Nanotechnol"},{"key":"4693_CR41","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1038\/s41467-019-10562-w","volume":"10","author":"C Qiu","year":"2019","unstructured":"Qiu C, Han H-H, Sun J, et al. Regulating intracellular fate of siRNA by endoplasmic reticulum membrane-decorated hybrid nanoplexes. Nat Commun. 2019;10:2702.","journal-title":"Nat Commun"},{"key":"4693_CR42","doi-asserted-by":"publisher","first-page":"100633","DOI":"10.1016\/j.mtbio.2023.100633","volume":"20","author":"S Zeng","year":"2023","unstructured":"Zeng S, Tang Q, Xiao M, et al. Cell membrane-coated nanomaterials for cancer therapy. Mater Today Bio. 2023;20:100633.","journal-title":"Mater Today Bio"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04693-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04693-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04693-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:38:54Z","timestamp":1790815134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04693-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4693"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04693-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of our hospital and performed according to institutional guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"917"}}